drugset / Trial / NCT05231746
A Study of hSTC810 With Advanced/Metastatic Solid Tumors (STCUBE-001)
NaSequentialOpen-labelTreatment
Summary
The Purpose of this study is to investigate the safety, tolerability, pharmacokinetics, and preliminary efficacy of hSTC810 monotherapy in participants with advanced solid tumors.
Timeline
- Start
- 2022-04-18
- Primary completion
- 2024-02-29
- Completion
- 2024-02-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nelmastobart | Monoclonal antibody | — | Intravenous |